Paving the way to better care
A public-private international research collaboration aiming to personalise prevention and treatment of cardiovascular disease.
What moves us
The challenge of cardiovascular disease
Cardiovascular disease (CVD) is a highly prevalent disease that poses challenges to healthcare systems worldwide. In Europe alone, it affects over 85 million people – a number that is rising due to an aging population and unhealthy lifestyles.
Despite medical advancements, treating CVD effectively remains challenging due to the complex interplay of risk factors and co-existing conditions in patients, such as diabetes and hypertension.
While a “one size fits all” approach persists, the diverse nature of CVD calls for personalized treatment strategies that improve care for patients. That’s the ultimate goal of iCARE4CVD.
iCARE4CVD’s vision is to work towards a future where CVD is better understood, more effectively treated, and less devastating for individuals and communities.
Number of people affected by CVD
> 500 million worldwide
Number of people that die from CVD
~ 17 million worldwide
More about iCARE4CVD
iCARE4CVD approach
From one-size-fits-all to personalised care
By creating one database gathering data from more than 1 million patients and using artificial intelligence, iCARE4CVD will look for new strategies to shift from a one-size-fits-all approach to personalised care.
The project will focus on improving four key areas of current CVD healthcare by:
-
Enhancing early diagnosis of patients at risk with cardiovascular disease -
Developing and assign risk levels to patients, defining those who need urgent intervention -
Predict how individuals will respond to treatment through the application of AI-based tools -
Ensure the inclusion of patient-supported outcomes by incorporating their unique perspectives into every area of our work
34 leading partners
from civil society, academia,
and industry
22 million EUR
in funding
4.5 years
of project duration
The project will achieve this by:
Collecting large amounts of patient cohorts…
covering patients of all CVD stages – from early risk to established heart failure
Generating a federated database…
to ensure private and confidential remote access to data on an individual level
Determining the value of biomarkers from different sources…
such as blood, imaging, digital wearables, to support early detection, monitoring, and treatment guidance for the entire spectrum of patients
Conducting in-depth qualitative research with patients and other stakeholders…
to build a motivational framework for self-care by patients and ensure their needs are incorporated into the outputs of the project
Developing artificial intelligence (AI)-based models to support diagnosis and predict risk and treatment responses…
to map the complete patient journey and response to interventions in CVD
Validating AI-based models prospectively towards precision medicine…
enabling the development of personalized care pathways
iCARE4CVD partners
iCARE4CVD brings together 33 leading international partners from civil society, academia and industry, and is lead by Maastricht University and global
healthcare company Novo Nordisk.
Contact us
Have any questions?
Send us a message.
Project coordinator:
- Hans-Peter Brunner La-Rocca (Maastricht University)
Project lead:
- Nicholas Ciccone (Novo Nordisk)
Project managers:
- Misha Schepers (Maastricht University
- Mafalda Ferreira (Catalyze)
Info
Press
Info
Press
Stay In the loop:
Subscribe to our newsletter
Subscribe to our newsletter to stay up to date with all the most recent information about iCARE4CVD.